We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Bausch + Lomb

News List

Yehia Hashad Will Join Bausch + Lomb as EVP of R&D and CMO FirstWordPharma
January 21, 2022
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") has announced that Dr. Yehia Hashad will join Bausch + Lomb Corporation ("Bausch + Lomb") as executive vice president...
FDA Approves Bausch + Lomb Alaway Preservative Free Ophthalmic Solution americanpharmaceuticalreview
October 09, 2020
Bausch Health, Bausch + Lomb, and Eton Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved Alaway® Preservative Free (ketotifen fumarate) ophthalmic solution, 0.035%, antihistamine eye drops (EM-100) ...
Bausch + Lomb Announces FDA Approval of LOTEMAX SM 0.38% americanpharmaceuticalreview
February 27, 2019
Bausch + Lomb announced the U.S. Food and Drug Administration (FDA) has approved LOTEMAX SM (loteprednol etabonate ophthalmic gel) 0.38%...